Target Name: LOC105377981
NCBI ID: G105377981
Review Report on LOC105377981 Target / Biomarker Content of Review Report on LOC105377981 Target / Biomarker
LOC105377981
Other Name(s): Uncharacterized LOC105377981 | uncharacterized LOC105377981

LOC105377981: A Potential Drug Target and Biomarker

LOC105377981 is a gene that has not yet been assigned a specific function, but it is known to encode a protein that is expressed in various tissues and organs, including the brain, heart, and liver. The protein produced by this gene has been shown to play a role in the development and progression of certain diseases, which has led to its potential as a drug target or biomarker.

The protein produced by LOC105377981 is a member of the known as the Kallikrein-related peptidases (KrP) family. This family of proteins is involved in the regulation of extracellular matrix (ECM) components, which are vital for tissue repair and regeneration. KrP proteins have also been shown to play a role in the development of certain diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of KrP proteins is their ability to generate small, simple peptides that can be involved in various cellular processes. These peptides, known as kallikrein peptides, have been shown to have a variety of functions, including modulating the activity of enzymes, activating intracellular signaling pathways, and participating in the regulation of cellular signaling pathways.

LOC105377981 has been shown to generate a specific kallikrein peptide, known as KL-K156, which has been shown to have various physiological functions. For example, KL-K156 has been shown to regulate the activity of a protein called FAK, which is involved in cell signaling and adhesion. This suggests that LOC105377981 may be involved in the regulation of cellular signaling pathways and the development of certain diseases.

Another potential function of LOC105377981 is its role in the development of certain diseases. For example, LOC105377981 has been shown to be expressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells. This suggests that LOC105377981 may be involved in the development and progression of this disease.

In addition to its potential involvement in the development of certain diseases, LOC105377981 also has potential as a drug target or biomarker. For example, LOC105377981 has been shown to be involved in the regulation of cellular signaling pathways, which makes it a potential target for small molecules that can modulate the activity of these pathways. Additionally, the protein produced by LOC105377981 is a member of the KrP family, which has been shown to play a role in the regulation of extracellular matrix components. This suggests that LOC105377981 may be involved in the regulation of ECM components, which could make it a potential target for drugs that target the activity of these components.

In conclusion, LOC105377981 is a gene that has not yet been assigned a specific function, but it is known to encode a protein that is involved in the regulation of various cellular processes. The protein produced by this gene has been shown to play a role in the development and progression of certain diseases, which has led to its potential as a drug target or biomarker. Further research is needed to fully understand the functions of LOC105377981 and its potential as a drug.

Protein Name: Uncharacterized LOC105377981

The "LOC105377981 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377981 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105